Dermira Inc. | Mutual Funds
Mutual Funds that own Dermira Inc.
FTIF SICAV - Franklin Biotechnology Discovery Fund
1,187,000
2.82%
564,500
0.49%
06/30/2018
Vanguard Total Stock Market Index Fund
948,079
2.25%
0
0%
07/31/2018
iShares Russell 2000 ETF
740,106
1.76%
-396
0.01%
09/06/2018
Biotech Growth Trust Plc (The)
500,485
1.19%
75,127
0.69%
09/30/2017
iShares Nasdaq Biotechnology ETF
482,578
1.14%
-6,300
0.05%
09/06/2018
Vanguard Extended Market Index Fund
465,309
1.11%
0
0.01%
07/31/2018
Carnegie Global Health Care Fund
399,496
0.95%
-25,121
2.06%
08/31/2018
Franklin Biotechnology Discovery Fund
390,600
0.93%
82,000
0.26%
03/31/2018
iShares US Pharmaceuticals ETF
340,871
0.81%
0
0.69%
09/06/2018
Eventide Healthcare & Life Sciences Fund
334,000
0.8%
0
0.46%
06/29/2018
| Address |
275 Middlefield Road
Menlo Park California 94025
United States
|
|
Employees
|
- |
| Website |
http://www.dermira.com |
| Updated |
07/08/2019 |
| Dermira, Inc. is a biopharmaceutical company, which engages in the provision of biotech ingenuity to medical dermatology. It focuses on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis, psoriasis, and acne. The company was founded by Thomas G. |
